ClinicalTrials.Veeva

Menu

A Comparison of the Outcomes of Distal Fingertip Amputations Treated With Either Artificial (Xeroform) or Biological Dressings

NYU Langone Health logo

NYU Langone Health

Status

Withdrawn

Conditions

Finger Injuries
Amputation, Traumatic

Treatments

Other: Skin Graft
Other: Bacitracin

Study type

Observational

Funder types

Other

Identifiers

NCT03968835
18-00132

Details and patient eligibility

About

This is a prospective study looking to evaluate whether the treatment outcomes for patients who sustain a distal fingertip amputation are improved or no different when using biological dressings versus artificial dressings.

Sex

All

Ages

Under 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All individuals presenting at Bellevue Hospital for evaluation and treatment of a finger amputation distal to the germinal matrix that present along with the amputated distal fingertip unit.

Exclusion criteria

  • replantation candidate, incomplete distal finger-tip amputation

Trial design

0 participants in 2 patient groups

Biological Dressings
Description:
Bacitracin will be applied and covered with xeroform and gauze
Treatment:
Other: Bacitracin
Artificial Dressings
Description:
the amputated composite skin and soft tissue unit will be thinned out to become a full thickness skin graft
Treatment:
Other: Skin Graft

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems